CenterHigh
KABC / ABC7 Los AngelesNews report · Aug 6, 9:33 AM
FDA approves Moderna's m RNA seasonal flu vaccine
The vaccine, m FLUSIVA, is expected to be available for people 50 and older for the 2026-2027 respiratory illness season.
← Today's headlines
8 sources checked · 2 source groups included · 26m ago
Still Watching
FDA approves Moderna's m RNA seasonal flu vaccine
Forbes and American Greatness describe the same event in different terms.
0 Left6 Center2 Right
STILL WATCHING
As of August 6, 2026 at 9:33 AM, this is how Optics News reads the wording differences in this story.
What happened The vaccine, m FLUSIVA, is expected to be available for people 50 and older for the 2026-2027 respiratory illness season.
The headline split The center frames it as "FDA approves Moderna's m RNA seasonal flu vaccine". The right frames it as "FDA Approves New m RNA Jab".
Match confidence Medium confidence. 8 sources across 2 bias buckets. Useful framing signal — check the source list before sharing.
Same-event confidenceMedium
8 sources across 2 bias buckets agree on the event.
Framing confidenceModerate
56/99 — meaningful wording shift across the spectrum.
WHAT EACH SIDE EMPHASIZED
Left / center-leftNo matching source in this bucket yet.
Optics keeps watching for pickup.
CenterFDA approves Moderna's m RNA seasonal flu vaccine
KABC / ABC7 Los Angeles · Center · News report
Right / center-rightMorning Greatness: FDA Approves Moderna’s m RNA Seasonal Flu Vaccine
American Greatness · Right · News report
SEE THE HEADLINES
Open source
CenterHigh
WLS / ABC7 ChicagoNews report · Aug 6, 9:33 AM
FDA approves Moderna's m RNA seasonal flu vaccine
The vaccine, m FLUSIVA, is expected to be available for people 50 and older for the 2026-2027 respiratory illness season.
CenterHigh
KGO / ABC7 San FranciscoNews report · Aug 6, 9:33 AM
FDA approves Moderna's m RNA seasonal flu vaccine
The vaccine, m FLUSIVA, is expected to be available for people 50 and older for the 2026-2027 respiratory illness season.
CenterHigh
WPVI / 6abc PhiladelphiaNews report · Aug 6, 9:33 AM
FDA approves Moderna's m RNA seasonal flu vaccine
The vaccine, m FLUSIVA, is expected to be available for people 50 and older for the 2026-2027 respiratory illness season.
CenterHigh
KTRK / ABC13 HoustonNews report · Aug 6, 9:33 AM
FDA approves Moderna's m RNA seasonal flu vaccine
The vaccine, m FLUSIVA, is expected to be available for people 50 and older for the 2026-2027 respiratory illness season.
RightMixed
American GreatnessNews report · Aug 6, 9:02 AM
Morning Greatness: FDA Approves Moderna’s m RNA Seasonal Flu Vaccine
Good Thursday morning. Here is what’s on President Trump’s agenda today: 8:00 AM THE PRESIDENT participates in Executive Time 10:00 AM THE PRESIDENT participates in […] Source
Show all 8 sources
CenterMostly Factual
ForbesNews report · Aug 6, 6:44 AM
FDA Approves First m RNA Flu Vaccine For Older Adults
The approval of Moderna’s new flu vaccine comes months after the FDA faced backlash for refusing to review the shot.
RightLow
100 Percent Fed UpNews report · Aug 6, 5:32 AM
FDA Approves New m RNA Jab
The Food and Drug Administration (FDA) on Wednesday approved the first influenza jab in the United States to use m RNA […]
Details56/99 Wording Gap · Medium confidence · 8 sources
56/99 Wording GapMedium confidence8 sources · 2 bias bucketsLive match · 8 sources · 2 buckets · comparable news formatFormats: News report
SOURCE MAP CHANGES
Aug 6, 5:32 AM: 100 Percent Fed Up joined the source map.
Aug 6, 6:44 AM: Forbes joined the source map.
Aug 6, 9:02 AM: American Greatness joined the source map.
Aug 6, 9:33 AM: KABC / ABC7 Los Angeles joined the source map.
Now: Wording Gap is 56/99 and story health is live match · 8 sources · 2 buckets · comparable news format.